1. Thomas T, Kaye PV, Ragunath K, Aithal G. Efficacy, safety, and predictive factors for a positive yield of EUS-guided Trucut biopsy: a large tertiary referral center experience. Am J Gastroenterol. 2009; 104:584–591. PMID:
19262518.
Article
2. Larghi A, Verna EC, Stavropoulos SN, Rotterdam H, Lightdale CJ, Stevens PD. EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study. Gastrointest Endosc. 2004; 59:185–190. PMID:
14745390.
Article
3. Iglesias-Garcia J, Poley JW, Larghi A, et al. Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc. 2011; 73:1189–1196. PMID:
21420083.
Article
4. Bang JY, Hebert-Magee S, Trevino J, Ramesh J, Varadarajulu S. Randomized trial comparing the 22-gauge aspiration and 22-gauge biopsy needles for EUS-guided sampling of solid pancreatic mass lesions. Gastrointest Endosc. 2012; 76:321–327. PMID:
22658389.
Article
5. Iwashita T, Nakai Y, Samarasena JB, et al. High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions. Gastrointest Endosc. 2013; 77:909–915. PMID:
23433596.
Article
6. Nagula S, Pourmand K, Aslanian HR, et al. EUS-fine needle aspiration (FNA) vs. EUS-fine needle biopsy (FNB) for solid mass lesions: interim analysis of a large multicenter, randomized clinical trial. Gastrointest Endosc. 2013; 77(5 Suppl):AB357–AB358.
7. Strand DS, Shami VM, Sauer BG, Wang AY. EUS-guided 22-gauge fine needle aspiration is superior to EUS-guided 22-gauge core needle biopsy in the evaluation of solid pancreatic neoplasms. Gastrointest Endosc. 2013; 77(5 Suppl):AB403.
8. Korenblit J, Singh H, Butt M, et al. Prospective randomized trial of the 22G EchoTip Procore™ needle versus the 22G Cook EchoTip Ultra 3® needle in patients with solid mass lesions undergoing EUS-guided fine needle aspiration (FNA). Gastrointest Endosc. 2013; 77(5 Suppl):AB178.
9. Vanbiervliet G, Fumex F, Saint-Paul MC, et al. Prospective randomized controlled trial with crossover of endoscopic ultrasound fine needle aspiration (EUS-FNA) using 22G ProCore and 22G EchoTip needle for solid pancreatic mass: the "Picore" study. Gastrointest Endosc. 2013; 77(5 Suppl):AB178.
10. Ramay F, Singh M, Sood V. Retrospective study comparing yield of EUS 22G FNA/FNB of abnormal lymph nodes: single tertiary referral center experience. Gastrointest Endosc. 2013; 77(5 Suppl):AB360.
11. Choi HJ, Moon JH, Kim HK, et al. Comparison of EUS-fine needle biopsy with EUS-fine needle aspiration as a historical control for diagnosis of pancreatic solid masses. Gastrointest Endosc. 2013; 77(5 Suppl):AB401.
12. Singh M, Ramay F, Sood V. EUS FNA/FNB of pancreatic mass lesions: single tertiary referral center experience. Gastrointest Endosc. 2013; 77(5 Suppl):AB402.
13. De La Mora-Levy JG, Florez-Sarmiento CF, Alonso-Larraga JO, Campuzano JO, Del Monte JS, Hernandez-Guerrero A. Direct comparison between Procore™, and non-Procore™ fine needle aspiration biopsy needles: does it make any difference in expert hands? Gastrointest Endosc. 2013; 77(5 Suppl):AB360.
14. Larghi A, Verna EC, Ricci R, et al. EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study. Gastrointest Endosc. 2011; 74:504–510. PMID:
21872709.
Article
15. Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc. 2012; 76:336–343. PMID:
22817786.
Article